Publication | Closed Access
Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I.
52
Citations
4
References
2010
Year
The low false-positive rate (high specificity) and the high sensitivity of the AHPV makes this assay suitable for use as a primary assay for detecting cervical disease in a screening setting.
| Year | Citations | |
|---|---|---|
Page 1
Page 1